Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02597231

Melatonin and Sleep in Preventing Delirium in the Hospital (MELO)

Melatonin and Sleep in Preventing Delirium in the Hospital: A Randomized Placebo-controlled Trial

Sponsor: Scripps Clinic

Conditions Delirium

Updated 6 times since 2017 Last updated: Oct 3, 2017 Started: Nov 30, 2015 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02597231, this PHASE1/PHASE2 trial focuses on Delirium and remains completed. Sponsored by Scripps Clinic, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Oct 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

Status: Not Yet Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Oct 2017 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Scripps Clinic
Scripps Health

Data source: Scripps Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• La Jolla, United States